AI Portfolio Summary
In 2025 Q4, Kynam Capital Management, LP maintained a portfolio of 41 distinct positions. The most significant new addition to the portfolio was BEAM THERAPEUTICS IN, which now represents 1.66% of the total fund value. They heavily accumulated shares in CYTOMX THERAPEUTICS , increasing their position by 145.9%. Conversely, Kynam Capital Management, LP completely exited their position in EDGEWISE THERAPEUTIC.
Total Positions
41
Quarter
2025 Q4
Top Holding
COGT (14.0%)
Top 10 Concentration
71.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-41 of 41
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 13.99% | 8.43% |
#1
3
Prev: #4
|
6.0 | -1,720,949 | -21.8% |
P
S
|
6,165,223 | $218,988,721 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 11.11% | 8.71% |
#2
1
Prev: #3
|
6.0 | -594,749 | -14.8% |
P
S
|
3,433,051 | $173,849,703 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 10.81% | 9.76% |
#3
1
Prev: #2
|
5.5 | -469,041 | -5.5% |
P
S
|
8,050,959 | $169,150,649 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 10.31% | 11.75% |
#4
3
Prev: #1
|
5.0 | -157,549 | -2.6% |
P
S
|
5,943,180 | $161,416,769 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 8.61% | 8.24% |
#5
Prev: #5
|
4.4 | -149,253 | -4.9% |
P
S
|
2,922,335 | $134,836,537 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BCRX
BIOCRYST PHARMA...
|
Healthcare | 4.67% | 5.31% |
#6
2
Prev: #8
|
2.4 | -23,744 | -0.3% |
P
S
|
9,366,526 | $73,058,903 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BEAM
BEAM THERAPEUTI...
|
Healthcare | 4.32% | 4.55% |
#7
2
Prev: #9
|
2.2 | -77,433 | -3.1% |
P
S
|
2,440,214 | $67,642,732 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 2.92% | 7.11% |
#8
2
Prev: #6
|
1.2 | -2,957,386 | -66.8% |
P
S
|
1,470,541 | $45,763,236 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TYRA
TYRA BIOSCIENCE...
|
Healthcare | 2.63% | 2.43% |
#9
5
Prev: #14
|
1.1 | -765,506 | -32.9% |
P
S
|
1,564,492 | $41,130,495 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 2.51% | 6.01% |
#10
3
Prev: #7
|
1.0 | -1,059,375 | -52.8% |
P
S
|
945,830 | $39,270,862 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 2.44% | 0.87% |
#11
12
Prev: #23
|
4.0 | 5,319,574 | 145.9% |
P
S
|
8,966,077 | $38,195,488 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 2.39% | 1.49% |
#12
5
Prev: #17
|
1.5 | -198,248 | -9.1% |
P
S
|
1,970,357 | $37,377,672 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 2.36% | 2.49% |
#13
Prev: #13
|
0.9 | -2,390,948 | -52.4% |
P
S
|
2,169,105 | $36,874,785 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 2.06% | 1.02% |
#14
8
Prev: #22
|
3.3 | 811,960 | 35.3% |
P
S
|
3,114,132 | $32,231,266 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 1.90% | 2.73% |
#15
5
Prev: #10
|
1.3 | -152,805 | -15.1% |
P
S
|
856,462 | $29,727,796 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 1.88% | 2.61% |
#16
5
Prev: #11
|
0.8 | -1,065,201 | -53.3% |
P
S
|
934,799 | $29,483,560 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 1.87% | 0.55% |
#17
10
Prev: #27
|
3.7 | 1,204,783 | 198.8% |
P
S
|
1,810,954 | $29,246,907 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BEAM
CALL
BEAM THERAPEUTI...
|
CALL Option | 1.66% | — |
#18
Prev: #—
|
4.2 | 937,000 | no change |
NEW
|
937,000 | $25,973,640 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
APLS
APELLIS PHARMAC...
|
Healthcare | 1.46% | 1.36% |
#19
Prev: #19
|
2.6 | 100,000 | 12.4% |
P
S
|
908,607 | $22,824,208 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DVAX
DYNAVAX TECHNOL...
|
Healthcare | 1.35% | 1.59% |
#20
4
Prev: #16
|
0.5 | -769,687 | -35.9% |
P
S
|
1,375,632 | $21,157,220 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BNR
BURNING ROCK BI...
|
Healthcare | 1.28% | 0.64% |
#21
4
Prev: #25
|
1.5 | no change | no change |
P
S
|
994,883 | $20,046,892 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 1.26% | 1.69% |
#22
7
Prev: #15
|
0.5 | -431,843 | -45.5% |
P
S
|
517,884 | $19,788,348 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.14% | 1.25% |
#23
3
Prev: #20
|
1.0 | -34,605 | -5.1% |
P
S
|
640,395 | $17,770,961 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ENGN
ENGENE HOLDINGS...
|
Healthcare | 0.86% | 2.54% |
#24
12
Prev: #12
|
0.3 | -3,501,192 | -70.1% |
P
S
|
1,492,898 | $13,480,869 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.77% | 1.12% |
#25
4
Prev: #21
|
0.3 | -1,462,755 | -50.7% |
P
S
|
1,424,259 | $12,049,231 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 0.51% | — |
#26
Prev: #—
|
3.7 | 702,884 | no change |
NEW
|
702,884 | $7,935,560 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DSGN
DESIGN THERAPEU...
|
Healthcare | 0.47% | 0.58% |
#27
1
Prev: #26
|
0.2 | -244,973 | -23.8% |
P
S
|
784,606 | $7,359,604 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 0.35% | 0.33% |
#28
4
Prev: #32
|
0.1 | -4,608,509 | -90.6% |
P
S
|
479,590 | $5,548,856 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMRN
AMARIN CORP PLC
|
Healthcare | 0.35% | 0.70% |
#29
5
Prev: #24
|
0.1 | -186,838 | -32.4% |
P
S
|
389,273 | $5,432,305 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GERN
GERON CORP
|
Healthcare | 0.29% | 0.35% |
#30
1
Prev: #31
|
1.1 | no change | no change |
P
S
|
3,456,318 | $4,562,340 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CLYM
CLIMB BIO INC
|
Healthcare | 0.26% | 0.15% |
#31
4
Prev: #35
|
1.1 | no change | no change |
P
S
|
1,028,341 | $4,113,364 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRBU
CARIBOU BIOSCIE...
|
Healthcare | 0.25% | 0.53% |
#32
3
Prev: #29
|
0.6 | -564,472 | -18.4% |
P
S
|
2,503,302 | $3,980,250 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
OMER
PUT
OMEROS CORP
|
PUT Option | 0.22% | — |
#33
Prev: #—
|
3.6 | 200,000 | no change |
NEW
|
200,000 | $3,436,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 0.20% | — |
#34
Prev: #—
|
3.6 | 185,482 | no change |
NEW
|
185,482 | $3,175,452 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRQR
PROQR THRAPEUTI...
|
Healthcare | 0.20% | 0.26% |
#35
1
Prev: #34
|
0.6 | -83,145 | -5.0% |
P
S
|
1,566,317 | $3,163,960 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALEC
ALECTOR INC
|
Healthcare | 0.20% | — |
#36
Prev: #—
|
3.6 | 2,000,000 | no change |
NEW
|
2,000,000 | $3,120,000 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRLD
PRELUDE THERAPE...
|
Healthcare | 0.15% | — |
#37
Prev: #—
|
3.6 | 788,867 | no change |
NEW
|
788,867 | $2,287,714 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #33) |
0.0 | -253,979 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 0.00% | 0.52% |
Sold All 😨
(Was: #30) |
0.0 | -282,412 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IRWD
IRONWOOD PHARMA...
|
Healthcare | 0.00% | 0.53% |
Sold All 😨
(Was: #28) |
0.0 | -5,466,825 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 0.00% | 1.49% |
Sold All 😨
(Was: #18) |
0.0 | -67,588 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-41 of 41 holdings